糖心vlog

[Skip to Navigation]
Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue
糖心vlog Home
JAMA Health Forum
Sign In
New Online Past Issues
糖心vlog Statement on Potentially Offensive Content

October 2024 - January 2020

Decade

Year

Issue

October 2023, Vol 4, No. 10

JAMA Forum

Worse Access, Quality, and Leadership鈥擱edressing the Affirmative Action Ruling鈥檚 Litany of Harms

Michael O. Mensah, MD, MHS, MPH; Samuel R. Sommers, PhD; Benjamin D. Sommers, MD, PhD
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e234099. doi:10.1001/jamahealthforum.2023.4099

This JAMA Forum discusses the US Supreme Court鈥檚 ruling on affirmative action in the context of the potential harms to access to care, quality of care, and leadership for the health care system.

How Much Safety Did the Social Safety Net Provide During the COVID-19 Pandemic?

Katherine Baicker, PhD
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e234237. doi:10.1001/jamahealthforum.2023.4237

This JAMA Forum discusses the successes, failures, and lessons learned regarding the performance of US social safety-net programs during the COVID-19 pandemic.

Health System Change in the Wake of COVID-19

David M. Cutler, PhD
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e234355. doi:10.1001/jamahealthforum.2023.4355

This JAMA Forum discusses resiliency, telehealth, the health care labor force, and public health in the context of the health system changes occurring since the start of the COVID-19 pandemic.

Complexity in the US Health Care System Is the Enemy of Access and Affordability

Larry Levitt, MPP; Drew Altman, PhD
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e234430. doi:10.1001/jamahealthforum.2023.4430

This JAMA Forum discusses the complexity of the US health care system, including the types of coverage and many plans offered, denial or other problems accessing coverage, and confusion regarding explanations of benefits and billing issues.

Viewpoint

Hospital Equity Rating Metrics鈥擯romise, Pitfalls, and Perils

Sherita Hill Golden, MD, MHS; Neil R. Powe, MD, MPH, MBA
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e233188. doi:10.1001/jamahealthforum.2023.3188

This Viewpoint addresses several considerations regarding equity metrics across hospital regulatory and accrediting organizations and suggestions for improvement.

New Opportunities to Strengthen Medicaid Managed Care Network Adequacy Standards

Jane M. Zhu, MD, MPP, MSHP; Kranti C. Rumalla, BA; Daniel Polsky, PhD
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e233194. doi:10.1001/jamahealthforum.2023.3194

This Viewpoint discusses new standards proposed by the Centers for Medicare & Medicaid Services for ensuring that Medicare managed care networks meet enrollees鈥� needs.

Rebalancing Controlled Substance Regulations in Telemedicine

Jacob T. Kannarkat, MD; Joseph T. Kannarkat, MPP; John Torous, MD, MBI
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e233251. doi:10.1001/jamahealthforum.2023.3251

This Viewpoint elucidates major components of the proposed rules about controlled substance prescribing in telehealth, highlights evolving considerations with the US Drug Enforcement Agency鈥檚 approach, and offers potential improvements before finalization of the rules.

Achieving the Potential of Naloxone Saturation by Measuring Distribution

Olivia K. Sugarman, PhD, MPH; Eric G. Hulsey, DrPH; Daliah Heller, PhD
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e233338. doi:10.1001/jamahealthforum.2023.3338

This Viewpoint advocates for improved strategies to measure naloxone distribution and evaluate how effectively naloxone reaches people most likely to experience or witness an opioid overdose.

The CMS Strategy to Promote Equity in Quality and Value Programs

Douglas B. Jacobs, MD, MPH; Michelle Schreiber, MD; Meena Seshamani, MD, PhD
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e233557. doi:10.1001/jamahealthforum.2023.3557

This Viewpoint discusses the CMS approach to incentivize excellent care for underserved populations.

Original Investigation

Educational Attainment and US Drug Overdose Deaths

David Powell, PhD
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e233274. doi:10.1001/jamahealthforum.2023.3274

This cross-sectional study uses data from the National Vital Statistics System to examine changes in rates of overdose deaths by level of educational attainment in the US from 2000 to 2021.

Propensity of US Military Personnel to Seek Mental Health Care When Community Psychiatric Capacity Changes

Yu-Chu Shen, PhD; Marigee Bacolod, PhD; Jennifer A. Heissel, PhD
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e233330. doi:10.1001/jamahealthforum.2023.3330

This cohort study evaluates whether the probability of mental health care visits by military personnel changes when psychiatrist capacity changes in their communities, when capacity is measured separately for military treatment facilities and civilian sectors.

Economic Burden Associated With Untreated Mental Illness in Indiana

Heather L. Taylor, PhD, MPH, RDH; Nir Menachemi, PhD; Amy Gilbert, JD, MPH; et al.
Abstract Full Text
open access has audio
JAMA Health Forum. 2023;4(10):e233535. doi:10.1001/jamahealthforum.2023.3535

This cross-sectional study of Indiana residents with untreated mental illness assesses the annual direct and indirect costs to the state鈥檚 economy.

  • Podcast: Economic Burden of Untreated Mental Illness in Indiana

Changes in Surgical Opioid Prescribing and Patient-Reported Outcomes After Implementation of an Insurer Opioid Prescribing Limit

Kao-Ping Chua, MD, PhD; Thuy D. Nguyen, PhD; Chad M. Brummett, MD; et al.
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e233541. doi:10.1001/jamahealthforum.2023.3541

This cross-sectional study determines whether patient-reported outcomes, such as pain control, changed after implementation of a commercial insurer鈥檚 5-day opioid prescribing limit.

Removal of Medicaid Prior Authorization Requirements and Buprenorphine Treatment for Opioid Use Disorder

Paul J. Christine, MD, PhD; Marc R. Larochelle, MD, MPH; Lewei (Allison) Lin, MD, MS; et al.
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e233549. doi:10.1001/jamahealthforum.2023.3549

This cross-sectional study assesses the association of removing prior authorization for buprenorphine to treat opioid use disorder with prescribing practices for Medicaid enrollees.

Use of Telemedicine and Quality of Care Among Medicare Enrollees With Serious Mental Illness

Andrew D. Wilcock, PhD; Haiden A. Huskamp, PhD; Alisa B. Busch, MD, MS; et al.
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e233648. doi:10.1001/jamahealthforum.2023.3648

This cohort study examines the use of telemental health services by Medicare beneficiaries with schizophrenia or bipolar I disorder, and whether outcomes differ according to a practice鈥檚 extent of telemedicine use.

Public Views on Medicaid Work Requirements and Mandatory Premiums in Kentucky

Kristen Underhill, JD, DPhil; Elizabeth F. Bair, MS; Erica L. Dixon, PhD; et al.
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e233656. doi:10.1001/jamahealthforum.2023.3656

This survey study examines views of adults in Kentucky regarding the design of Medicaid work requirements and premiums.

Research Letter

Brand Differences in Underage Tobacco Use as Evidence for Targeted Sanctions鈥擱eviving the Lookback

Abigail S. Friedman, PhD; Alex C. Liber, PhD
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e233463. doi:10.1001/jamahealthforum.2023.3463

This survey study uses data from the 2020-2021 National Survey on Drug Use and Health to estimate brand differences in underage cigarette and cigar use in the US.

Pharmacy Benefit Manager Pricing and Spread Pricing for High-Utilization Generic Drugs

T. Joseph Mattingly II, PharmD, MBA, PhD; Kenechukwu C. Ben-Umeh, BPharm; Ge Bai, PhD, CPA; et al.
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e233660. doi:10.1001/jamahealthforum.2023.3660

This cross-sectional study uses Medicare Part D claims for high-utilization generic drugs to analyze gross profits accumulated by pharmacy benefit managers, pharmacies, wholesalers, and manufacturers in the pharmaceutical supply chain.

Transparency in Coverage Data and Variation in Prices for Common Health Care Services

Benjamin L. Chartock, PhD; Kosali Simon, PhD; Christopher M. Whaley, PhD
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e233663. doi:10.1001/jamahealthforum.2023.3663

This cross-sectional study describes the health care prices publicly posted by Humana and the price variations by geography, service, and other factors.

Editorial

Time to Treat the Climate and Nature Crisis as One Indivisible Global Health Emergency

Kamran Abbasi; Parveen Ali; Virginia Barbour; et al.
Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e234347. doi:10.1001/jamahealthforum.2023.4347
Correction

Error in Figure 1

Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e234083. doi:10.1001/jamahealthforum.2023.4083
JAMA Health Forum Masthead

JAMA Health Forum

Abstract Full Text
open access
JAMA Health Forum. 2023;4(10):e232456. doi:10.1001/jamahealthforum.2023.2456
Most Viewed(30 Days) RSS link
Most Cited(3 Years) RSS Link
View more
View more
×
Access your subscriptions
Add or change institution
Access your subscriptions
Add or change institution
Sign in to access free PDF
Add or change institution
Save your search
Make a comment
Privacy Policy